Aurora Financial JournalXORTX Therapeutics Inc. (XRTX)
NASDAQ · Health care · Pharmaceutical Preparations · Financial statements, TTM figures and earnings dates
Annual financial statements are available for fiscal years 2019 to 2021, taken from the company's filings with the SEC.
Open interactive financials →Key financials
| CAD | FY2021 2021-12-31 | FY2020 2020-12-31 | FY2019 2019-12-31 |
|---|---|---|---|
| Income statement | |||
| Net income | −C$1.7M | −C$1.3M | −C$629.6K |
| Cash flow | |||
| Operating cash flow | −C$6.1M | −C$728.4K | −C$249.6K |
| Balance sheet | |||
| Cash and equivalents | C$18.9M | C$171.3K | C$58.6K |
| Total assets | C$22.0M | C$2.3M | – |
| Total liabilities | C$5.3M | C$1.0M | – |
| Shareholders' equity | C$16.7M | C$1.3M | −C$211.7K |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in CAD as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full XRTX page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, the statements exactly as filed with the SEC, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open XRTX financials →